govt.fyi
Back to HB 1301
Arkansas General Assembly· HB 1301Notification that HB1301 is now Act 511

An act TO AMEND THE PRIOR AUTHORIZATION TRANSPARENCY 10 ACT, the official text

Shown verbatim: the complete text as captured from the official PDF posted by the Arkansas General Assembly, fetched 2026-07-23. Page and line markers are part of the official record; nothing is edited or removed. The official bill page.
Stricken language would be deleted from and underlined language would be added to present law.

1 State of Arkansas      As Engrossed: H2/5/25 H2/20/25 H3/13/25

2 95th General Assembly                     A Bill

3 Regular Session, 2025                                           HOUSE BILL 1301

4

5 By: Representative L. Johnson

6 By: Senator Irvin

7

8                                For An Act To Be Entitled

9   AN ACT TO AMEND THE PRIOR AUTHORIZATION TRANSPARENCY

10  ACT; AND FOR OTHER PURPOSES.

11

12

13                                          Subtitle

14                       TO AMEND THE PRIOR AUTHORIZATION

15                       TRANSPARENCY ACT.

16

17 BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF ARKANSAS:

18

19  SECTION 1. Arkansas Code � 23-99-1103, concerning the definitions used

20 in the Prior Authorization Transparency Act, is amended to add an additional

21 subdivision to read as follows:

22  (23) "Gold card program" means the process described in �� 23-

23 99-1120 -- 23-99-1126 under which a healthcare provider may qualify for an

24 exemption from a healthcare insurer's or pharmacy benefits manager's prior

25 authorization requirements.

26

27 SECTION 2. Arkansas Code � 23-99-1120 is amended to read as follows:

28

29  23-99-1120. Initial exemption from prior authorization requirements

30 for healthcare providers providing certain healthcare services.

31  (a)(1) Except as provided under subdivision (a)(2) of this section,

32 beginning on and after January 1, 2024, a healthcare provider that received

33 approval for ninety percent (90%) or more of the healthcare provider's prior

34 authorization requests based on a review of the healthcare provider's

35 utilization of the particular healthcare services from January 1, 2022,

36 through June 30, 2022, shall not be required to obtain prior authorization

    *ANS112*                                                03-13-2025 09:57:51 ANS112
    As Engrossed: H2/5/25 H2/20/25 H3/13/25                                HB1301

1 for a particular healthcare service and shall be considered exempt from prior

2 authorization requirements through September 30, 2024.

3   (2) If a healthcare provider's use for a particular healthcare

4 service increases by twenty-five percent (25%) or more during the period

5 between January 1, 2024, and June 30, 2024, based on a review of the

6 healthcare provider's utilization of the particular healthcare service from

7 January 1, 2022, through June 30, 2022, then the healthcare insurer may

8 disallow the exemption from prior authorization requirements for the

9 healthcare provider for the particular healthcare service.

10  (b)(1) A healthcare insurer shall conduct an evaluation of the initial

11 six-month exemption period based on claims submitted between January 1, 2024,

12 through June 30, 2024, to determine whether to grant or deny an exemption for

13 each particular healthcare service that requires a prior authorization by the

14 healthcare insurer.

15  (2) The evaluation by the healthcare insurer shall be conducted

16 by using the retrospective review process under � 23-99-1122(c) and applying

17 the criteria under subsection (d) of this section.

18  (3) A healthcare insurer shall submit to a healthcare provider a

19 written statement of:

20  (A) The total number of payable claims submitted by or in

21 connection with the healthcare provider; and

22  (B) The total number of denied and approved prior

23 authorizations between January 1, 2022, through June 30, 2022.

24  (c)(1) No later than October 1, 2024, a healthcare insurer shall issue

25 a notice to each healthcare provider that either grants or denies a prior

26 authorization exemption to the healthcare provider for each particular

27 healthcare service.

28  (2) An exemption granted under this subdivision (c)(1) shall be

29 valid for at least twelve (12) months.

30  (d) Except as provided under subsection (f) subsection (c) of this

31 section or � 23-99-1125, a healthcare insurer that uses a prior authorization

32 process for healthcare services shall not require a healthcare provider to

33 obtain prior authorization for a particular healthcare service that a

34 healthcare provider has previously been subject to a prior authorization

35 requirement if, in the most recent six-month evaluation period as described

36 under subsection (e) subsection (b) of this section, the healthcare insurer

                          2                            03-13-2025 09:57:51 ANS112
    As Engrossed: H2/5/25 H2/20/25 H3/13/25                                 HB1301

1 has approved or would have approved no less than ninety percent (90%) of the

2 prior authorization requests submitted by the healthcare provider for that

3 particular healthcare service.

4   (e)(1)(b)(1) Except as provided under subsection (f) subsection (c) of

5 this section, a healthcare insurer shall evaluate whether or not a healthcare

6 provider qualifies for an exemption from prior authorization requirements

7 under subsection (d) subsection (a) of this section one (1) time every twelve

8 (12) months.

9   (2) The six-month period for the evaluation period described

10 under subsection (d) subsection (a) of this section shall be:

11                 (A) For a healthcare provider with an existing exemption

12 under this section, any consecutive six-month period during the twelve (12)

13 months following the effective date of the exemption;

14                 (B) For an initial healthcare provider, any consecutive

15 six-month period during the twelve (12) months following the healthcare

16 provider's first filed claim with the healthcare insurer;

17                 (C) For an initial healthcare insurer, any consecutive

18 six-month period during the twelve (12) months following the healthcare

19 insurer's commencement of operations subject to this subchapter; or

20                 (D)(i) For a healthcare provider denied an exemption under

21 this section, any consecutive six-month period during the twelve (12) months

22 before the healthcare provider's request for a new evaluation.

23                 (ii) A healthcare provider may request that the

24 healthcare insurer perform a new evaluation twelve (12) months after the most

25 recent denial.

26  (3) The healthcare insurer shall choose a six-month evaluation

27 period that allows time for:

28                 (A) The evaluation under subsection (d) subsection (a) of

29 this section;

30                 (B) Notice to the healthcare provider of the decision; and

31                 (C) Appeal of the decision for an independent review to be

32 completed by the end of the twelve-month period of the exemption.

33  (f)(c) A healthcare insurer may continue an exemption under subsection

34 (d) subsection (a) of this section without evaluating whether or not the

35 healthcare provider qualifies for the exemption under subsection (d)

36 subsection (a) of this section for a particular evaluation period.

                                  3          03-13-2025 09:57:51 ANS112
    As Engrossed: H2/5/25 H2/20/25 H3/13/25                                HB1301

1   (g)(d) A healthcare provider is not required to request an exemption

2 under subsection (d) subsection (a) of this section to quality qualify for

3 the exemption.

4   (h)(e)(1) A healthcare insurer may shall extend an exemption under

5 subsection (d) subsection (a) of this section to a group of healthcare

6 providers under the same tax identification number if either the healthcare

7 insurer or the healthcare provider elects to do so, and:

8                 (1)(A) A healthcare provider with an ownership interest in

9 the entity to which the tax identification number is assigned does not

10 object; or

11                (2)(B) The tax identification number is associated with a

12 hospital licensed in this state and the chief executive officer of the

13 hospital agrees to the exemption.

14             (2) If a healthcare insurer elects to extend an exemption under

15 subdivision (e)(1) of this section to a group of healthcare providers, the

16 healthcare insurer shall provide to each affected healthcare provider at

17 least sixty (60) days' prior notice of the election and of any modification

18 to or termination of the election.

19             (3) If, in the most recent six-month evaluation period, the

20 healthcare insurer approved or would have approved less than eighty percent

21 (80%) of the prior authorization requests submitted by a healthcare provider

22 for a particular healthcare service, the healthcare provider shall not be

23 eligible for inclusion under an exemption extended to healthcare providers

24 under the same tax identification number under this subsection.

25

26  SECTION 3. Arkansas Code � 23-99-1121(a), concerning the duration of a

27 prior authorization exemption under the Prior Authorization Transparency Act,

28 is amended to read as follows:

29  (a) Unless a prior authorization exemption is continued for a longer

30 period of time by a healthcare insurer under � 23-99-1120(f) � 23-99-1120(c),

31 a healthcare provider's exemption from prior authorization requirements under

32 � 23-99-1120 remains in effect until the later of:

33             (1) The thirtieth day after the date the healthcare insurer

34 notifies the healthcare provider of the healthcare insurer's determination to

35 rescind the exemption as described under � 23-99-1122, if the healthcare

36 provider does not appeal the healthcare insurer's determination within thirty

                                       4               03-13-2025 09:57:51 ANS112
    As Engrossed: H2/5/25 H2/20/25 H3/13/25                                 HB1301

1 (30) days of notification of the determination;

2             (2) If the healthcare provider appeals the determination within

3 thirty (30) days of notification of the determination, the fifth day after

4 the date an independent review organization affirms the healthcare insurer's

5 determination to rescind the exemption; or

6             (3) Twelve (12) months after the effective date of the

7 exemption.

8

9       SECTION 4. Arkansas Code � 23-99-1122(a), concerning the recission of

10 a prior authorization exemption under the Prior Authorization Transparency

11 Act, is amended to read as follows:

12      (a) A healthcare insurer may rescind an exemption from prior

13 authorization requirements of a healthcare provider under � 23-99-1120 only

14 if:

15            (1) The healthcare insurer makes a determination that, on the

16 basis of a retrospective review of a random sample of claims selected by the

17 healthcare insurer during the most recent evaluation period described by �

18 23-99-1120(e) � 23-99-1120(b), less than ninety percent (90%) of the claims

19 for the particular healthcare service met the medical necessity criteria that

20 would have been used by the healthcare insurer when conducting prior

21 authorization review for the particular healthcare service during the

22 relevant evaluation period;

23            (2) The healthcare insurer complies with other applicable

24 requirements specified in this section, including without limitation:

25            (A) Notifying the healthcare provider no less than twenty-

26 five (25) thirty (30) days before the proposed rescission is to take effect;

27 and

28            (B) Providing:

29            (i) An identification of the healthcare service that

30 an exemption is being rescinded, the date the notice is issued, and the

31 effective date of the rescission;

32            (ii) A plain-language explanation of how the

33 healthcare provider may appeal and seek an independent review of the

34 determination, the date the notice is issued, and the company's address and

35 contact information for returning the form by mail or email to request an

36 appeal;

                                        5          03-13-2025 09:57:51 ANS112
    As Engrossed: H2/5/25 H2/20/25 H3/13/25                                 HB1301

1                           (iii) A statement of the total number of payable

2 claims submitted by or in connection with the healthcare provider during the

3 most recent evaluation period that were eligible to be evaluated with respect

4 to the healthcare service subject to rescission, the number of claims

5 included in the random sample, and the sample information used to make the

6 determination, including without limitation:

7                           (a) Identification of each claim included in

8 the random sample;

9                           (b) The healthcare insurer's determination of

10 whether each claim met the healthcare insurer's screening criteria; and

11                          (c) For any claim determined to not have met

12 the healthcare insurer's screening criteria:

13                          (1) The principal reasons for the

14 determination that the claim did not meet the healthcare insurer's screening

15 criteria, including, if applicable, a statement that the determination was

16 based on a failure to submit specified medical records;

17                          (2) The clinical basis for the

18 determination that the claim did not meet the healthcare insurer's screening

19 criteria;

20                          (3) A description of the sources of the

21 screening criteria that were used as guidelines in making the determination;

22 and

23                          (4) The professional specialty of the

24 healthcare provider who made the determination;

25                          (iv) A space to be filled out by the healthcare

26 provider that includes:

27                          (a) The name, address, contact information,

28 and identification number of the healthcare provider requesting an

29 independent review;

30                          (b) An indication of whether or not the

31 healthcare provider is requesting that the entity performing the independent

32 review examine the same random sample or a different random sample of claims,

33 if available; and

34                          (c) The date the appeal is being requested;

35 and

36                          (v) An instruction to the healthcare provider to

                            6                       03-13-2025 09:57:51 ANS112
    As Engrossed: H2/5/25 H2/20/25 H3/13/25                                 HB1301

1 return the form to the healthcare insurer before the date the rescission

2 becomes effective; and

3                (3) The healthcare provider performs five (5) or fewer of

4 a particular healthcare service in the most recent six-month evaluation

5 period under � 23-99-1120(e) � 23-99-1120(b).

6

7      SECTION 5. Arkansas Code � 23-99-1122(c)(2), concerning the timeline a

8 healthcare insurer provides to a healthcare provider to provide medical

9 records under the Prior Authorization Transparency Act, is amended to read as

10 follows:

11           (2) A healthcare insurer shall provide a healthcare provider at

12 least thirty (30) sixty (60) days to provide the medical records requested

13 under subdivision (c)(1) of this section.

14

15     SECTION 6. Arkansas Code � 23-99-1126(a), concerning the payments to a

16 healthcare provider who has an exemption under the Prior Authorization

17 Transparency Act, is amended to read as follows:

18     (a)(1) A healthcare insurer shall not deny or reduce payment to a

19 healthcare provider for a healthcare service for which the healthcare

20 provider has qualified for an exemption from prior authorization requirements

21 under � 23-99-1120, including a healthcare service performed or supervised by

22 another healthcare provider, if the healthcare provider who ordered the

23 healthcare service received a prior authorization exemption based on medical

24 necessity or appropriateness of care unless the healthcare provider:

25               (1)(A) Knowingly and materially misrepresented the

26 healthcare service in a request for payment submitted to the healthcare

27 insurer with the specific intent to deceive the healthcare insurer and obtain

28 an unlawful payment from the healthcare insurer; or

29               (2)(B) Substantially failed to perform the healthcare

30 service.

31           (2)(A) Subdivision (a)(1) of this section does not constitute a

32 basis for a healthcare insurer to:

33                        (i) Request information from a healthcare provider;

34 or

35                        (ii) Delay reimbursement in order to obtain

36 information.

                                       7                03-13-2025 09:57:51 ANS112
    As Engrossed: H2/5/25 H2/20/25 H3/13/25                                HB1301

1   (B) A request for information under subdivision

2 (a)(2)(A)(i) of this section shall comply with applicable laws and rules.

3

4   SECTION 7. Arkansas Code � 23-99-1126(d), concerning the information

5 required in the notice to a healthcare provider under the Prior Authorization

6 Transparency Act, is amended to read as follows:

7   (d) Beginning on January 1, 2024, a A healthcare insurer shall provide

8 to a healthcare provider a notice that includes a:

9   (1) Statement that the healthcare provider has an exemption from

10 prior authorization requirements under � 23-99-1120;

11  (2) List of the healthcare services and health benefit plans to

12 which the exemption applies; and

13  (3) Statement of the duration of the exemption.

14

15  SECTION 8. Arkansas Code � 23-99-1127 is amended to read as follows:

16  23-99-1127. Applicability.

17  (a)(1) An organization or entity directly or indirectly providing a

18 plan or services to patients under the Medicaid Provider-Led Organized Care

19 Act, � 20-77-2701 et seq., or any other Medicaid-managed care program

20 operating in this state is exempt from �� 23-99-1120 -- 23-99-1126 if the

21 program, without limiting the program's application to any other plan or

22 program, develops and conforms to a program to reduce or eliminate prior

23 authorizations for a healthcare provider on or before January 1, 2025.

24  (2) The Arkansas Health and Opportunity for Me Program

25 established by the Arkansas Health and Opportunity for Me Act of 2021, � 23-

26 61-1001 et seq., or its successor program is exempt from �� 23-99-1120 -- 23-

27 99-1126, provided that the Arkansas Health and Opportunity for Me Program,

28 without limiting the Arkansas Health and Opportunity for Me Program's

29 application to any other plan or program, develops and conforms to a program

30 to reduce or eliminate prior authorizations for a healthcare provider on or

31 before January 1, 2025.

32  (3) A qualified health plan that is a health benefit plan under

33 the Patient Protection and Affordable Care Act, Pub. L. No. 111-148, and

34 purchased on the Arkansas Health Insurance Marketplace created under the

35 Arkansas Health Insurance Marketplace Act, � 23-61-801 et seq., for an

36 individual up to four hundred percent (400%) of the federal poverty level,

                                     8                03-13-2025 09:57:51 ANS112
    As Engrossed: H2/5/25 H2/20/25 H3/13/25                                HB1301

1 operating in this state is exempt from �� 23-99-1120 -- 23-99-1126 if the

2 qualified health plan, without limiting the program's application to any

3 other plan or program, develops and conforms to a program to reduce or

4 eliminate prior authorizations for a healthcare provider on or before January

5 1, 2025.

6       (b)(1)(A) The programs At least one (1) time every two (2) years, a

7 program under subsection (a) of this section to reduce or eliminate prior

8 authorization shall be:

9                          (A)(i) Submitted to the State Insurance Department;

10 and

11                         (B)(ii) Subject to approval by the Legislative

12 Council.

13                   (B) A program under subsection (a) of this section shall

14 include:

15                         (i) Data, statistics, and other appropriate

16 documentation demonstrating the effectiveness of the previously submitted

17 program in reducing or eliminating prior authorizations for a healthcare

18 provider; and

19                         (ii) For a program that does not eliminate prior

20 authorizations for a healthcare provider, specific initiatives or elements of

21 the program that reduce existing prior authorizations for a healthcare

22 provider.

23                   (C)(i) Upon submitting the program under subdivision

24 (b)(1) of this section, the submitting entity shall provide notice to each

25 healthcare provider that includes:

26                              (a) The complete program submission;

27                              (b) The deadline for a healthcare provider to

28 comment on the program submission; and

29                              (c) Instructions on how a healthcare provider

30 may comment on the program.

31                         (ii) A healthcare provider shall have at least

32 thirty (30) days to comment on a program submitted under subdivision (b)(1)

33 of this section.

34            (2) If a program is not submitted to the department and approved

35 by the Legislative Council on or before January 1, 2025 as required or does

36 not conform to the requirements of this section, the Medicaid-managed care

                                       9     03-13-2025 09:57:51 ANS112
    As Engrossed: H2/5/25 H2/20/25 H3/13/25                                 HB1301

1 program operating in this state, the Arkansas Health and Opportunity for Me

2 Program established by the Arkansas Health and Opportunity for Me Act of

3 2021, � 23-61-1001 et seq., or its successor program, and qualified health

4 plans under the Patient Protection and Affordable Care Act, Pub. L. No. 111-

5 148, and purchased on the Arkansas Health Insurance Marketplace created under

6 the Arkansas Health Insurance Marketplace Act, � 23-61-801 et seq., for an

7 individual up to four hundred percent (400%) of the federal poverty level,

8 operating in this state shall be subject to �� 23-99-1120 -- 23-99-1126 and �

9 23-99-1128 as of January 1, 2025.

10  (c) Any state or local governmental employee plan is exempt from ��

11 23-99-1120 -- 23-99-1126 and � 23-99-1128.

12  (d) A health benefit plan provided by a trust established under �� 14-

13 54-101 and 25-20-104 to provide benefits, including accident and health

14 benefits, death benefits, dental benefits, and disability income benefits, is

15 exempt from �� 23-99-1120 -- 23-99-1126.

16  (e)(1) Prescription drugs, medicines, biological products,

17 pharmaceuticals, or pharmaceutical services are exempt as a healthcare

18 service for purposes of �� 23-99-1120 -- 23-99-1126 until December 31, 2024

19 subject to the gold card program unless exempted from the gold card program

20 under � 23-99-1128(b).

21  (2)(A) As of January 1, 2025, the provisions of �� 23-99-1120 --

22 23-99-1126 shall apply to prescription drugs, medicines, biological products,

23 pharmaceuticals, or pharmaceutical services that have not been approved for

24 continuation of prior authorization under � 23-99-1128.

25  (B) For the products in subdivision (e)(2)(A) of this

26 section that have not been approved for continuation of prior authorization,

27 for purposes of � 23-99-1120, then:

28                          (i) Provisions regarding time periods specified

29 during calendar year 2022 shall instead apply to the same months during

30 calendar year 2023; and

31                          (ii) Provisions regarding time periods specified

32 during calendar year 2024 shall instead apply to the same months during

33 calendar year 2025.

34  (f)(1) Upon request, a healthcare insurer or a pharmacy benefits

35 manager shall send an eligibility file notification to a healthcare provider.

36  (2) An eligibility file notification under subdivision (f)(1) of

                                     10        03-13-2025 09:57:51 ANS112
    As Engrossed: H2/5/25 H2/20/25 H3/13/25                                 HB1301

1 this section shall indicate whether a subscriber is enrolled in a:

2   (A) Health benefit plan that is:

3                          (i) Self-insured under the Employee Retirement

4 Income Security Act of 1974, Pub. L. No. 93-406;

5                          (ii) A fully insured health benefit plan; or

6                          (iii) A self-funded health benefit plan;

7   (B) Qualified health benefit plan that is a health benefit

8 plan under the Patient Protection and Affordable Care Act, Pub. L. No. 111-

9 148, and purchased on the Arkansas Health Insurance Marketplace created under

10 the Arkansas Health Insurance Marketplace Act, � 23-61-801 et seq., for an

11 individual up to four hundred percent (400%) of the federal poverty level,

12 operating in this state; or

13  (C) Qualified health benefit plan that is a health benefit

14 plan under the Patient Protection and Affordable Care Act, Pub. L. No. 111-

15 148, and purchased as a health benefit plan under Arkansas Health Insurance

16 Marketplace created under the Arkansas Health Insurance Marketplace Act, �

17 23-61-801 et seq., for an individual over four hundred percent (400%) of the

18 federal poverty level.

19

20  SECTION 9. Arkansas Code � 23-99-1128 is amended to read as follows:

21  23-99-1128. Prescription drugs, medicines, biological products,

22 pharmaceuticals, or pharmaceutical services.

23  (a)(1) Beginning on January 1, 2024, a healthcare insurer or pharmacy

24 benefits manager shall submit a written request to the Arkansas State Board

25 of Pharmacy for any prescription drug, medicine, biological product,

26 pharmaceutical, or pharmaceutical service to be reviewed for a continuation

27 of prior authorization by a specified health benefit plan whether or not a

28 healthcare provider has met the criteria for an exemption from prior

29 authorization under �� 23-99-1120 -- 23-99-1126.

30  (2) The request under subdivision (a)(1) of this section shall

31 state the reason the request is being made for each prescription drug,

32 medicine, biological product, pharmaceutical, or pharmaceutical service for

33 the specified health benefit plan If a prescription drug, medicine,

34 biological product, pharmaceutical, or pharmaceutical service is not exempt

35 from the gold card program under subsection (b) of this section, then a

36 healthcare provider shall be reviewed by a healthcare insurer or pharmacy

                                11                   03-13-2025 09:57:51 ANS112
    As Engrossed: H2/5/25 H2/20/25 H3/13/25                                 HB1301

1 benefits manager under the gold card program for the prescription drug,

2 medicine, biological product, pharmaceutical, or pharmaceutical service.

3   (b)(1) The Arkansas State Board of Pharmacy and the Arkansas State

4 Medical Board, jointly, may establish criteria and procedures to review

5 whether a request made under subdivision (a)(1) of this section should be

6 granted for the requesting party and specified health benefit plan For a

7 prescription drug, medicine, biological product, pharmaceutical, or

8 pharmaceutical service to be exempt from the gold card program, a healthcare

9 insurer or pharmacy benefits manager may submit a written request to the

10 Arkansas State Board of Pharmacy for approval.

11  (2) A request under subdivision (b)(1) of this section shall

12 state the reason the request is being made for each prescription drug,

13 medicine, biological product, pharmaceutical, or pharmaceutical service for

14 which exemption from the gold card program is requested.

15  (3) The Arkansas State Board of Pharmacy and the Arkansas State

16 Medical Board, jointly, shall establish criteria and procedures to review

17 whether a request for exemption from the gold card program made under

18 subdivision (b)(1) of this section should be granted.

19  (4) The criteria established under subdivision (b)(3) of this

20 section shall include criteria related to the cost and the safety of the

21 prescription drug, medicine, biological product, pharmaceutical, or

22 pharmaceutical service.

23  (5) Under the criteria established and procedures described

24 under subdivision (b)(3) of this section, the Arkansas State Board of

25 Pharmacy and the Arkansas State Medical Board, jointly, shall determine

26 whether to approve a request to exempt a prescription drug, medicine,

27 biological product, pharmaceutical, or pharmaceutical service from the gold

28 card program.

29  (6) The Arkansas State Board of Pharmacy shall promptly notify

30 the entity that made the request of the joint decision made by the Arkansas

31 State Board of Pharmacy and the Arkansas State Medical Board.

32  (7) The decision of the Arkansas State Board of Pharmacy and the

33 Arkansas State Medical Board, jointly, regarding each prescription drug,

34 medicine, biological product, pharmaceutical, or pharmaceutical service shall

35 apply to all healthcare insurers or pharmacy benefits managers.

36  (8) The Arkansas State Board of Pharmacy shall post on the

                            12                     03-13-2025 09:57:51 ANS112
    As Engrossed: H2/5/25 H2/20/25 H3/13/25                                HB1301

1 Arkansas State Board of Pharmacy's website a list of prescription drugs,

2 medicines, biological products, pharmaceuticals, or pharmaceutical services

3 that are exempt from the gold card program.

4   (9) An approval for exemption from the gold card program is

5 valid for two (2) years from the date of the notice provided under

6 subdivision (b)(6) of this section.

7   (c)(1) The Arkansas State Board of Pharmacy and the Arkansas State

8 Medical Board, jointly, may determine whether or not a prescription drug,

9 medicine, biological product, pharmaceutical, or pharmaceutical service may

10 be subject to prior authorization by a health benefit plan under the criteria

11 and procedures under subsection (b) of this section.

12  (2) The Arkansas State Board of Pharmacy shall promptly notify

13 the entity that made the request of the joint decision made by the Arkansas

14 State Board of Pharmacy and the Arkansas State Medical Board.

15  (d) The Arkansas State Board of Pharmacy shall make available to any

16 person who requests it, a list for any health benefit plan of prescription

17 drugs, medicines, biological products, pharmaceuticals, or pharmaceutical

18 services that require a prior authorization under this section.

19

20  SECTION 10. Arkansas Code � 23-99-1129 is amended to read as follows:

21  23-99-1129. Appeals process for disallowance of prior authorization.

22  (a) If the Arkansas State Board of Pharmacy and the Arkansas State

23 Medical Board, jointly, disallow a prior authorization of a prescription

24 drug, medicine, biological product, pharmaceutical, or pharmaceutical service

25 requested under � 23-99-1128, a healthcare insurer, pharmacy benefits

26 manager, or other interested party may file an appeal to the State Insurance

27 Department within ninety (90) days of the disallowance of the prior

28 authorization.

29  (b) The healthcare insurer, pharmacy benefits manager, or other

30 interested party shall provide a notice of seven (7) days to the Arkansas

31 State Board of Pharmacy and the Arkansas State Medical Board of the

32 healthcare insurer's, pharmacy benefits manager's, or other interested

33 party's intent to file an appeal.

34  (c) No later than the thirtieth day after the date a healthcare

35 insurer, pharmacy benefits manager, or other interested party files an appeal

36 under subsection (a) of this section, the Insurance Commissioner shall

                                      13       03-13-2025 09:57:51 ANS112
    As Engrossed: H2/5/25 H2/20/25 H3/13/25                                 HB1301

1 appoint an independent review organization to review the appeal.

2   (c)(d) A healthcare insurer, pharmacy benefits manager, or other

3 interested party that files an appeal under subsection (a) of this section

4 shall pay for the independent review organization appointed under subsection

5 (b)(c) of this section to review the appeal.

6   (e)(1) If a healthcare insurer, pharmacy benefits manager, or other

7 interested party succeeds in its appeal and overturns the decision of the

8 Arkansas State Board of Pharmacy and the Arkansas State Medical Board, the

9 healthcare insurer, pharmacy benefits manager, or other interested party

10 shall be reimbursed for fifty percent (50%) of the cost remitted to the

11 independent review organization under subsection (d) of this section.

12  (2) The Arkansas State Board of Pharmacy and the Arkansas State

13 Medical Board shall each provide twenty-five percent (25%) of the total

14 reimbursement to the healthcare insurer, pharmacy benefits manager, or other

15 interested party under subdivision (e)(1) of this section.

16  (d)(f) A healthcare insurer, pharmacy benefits manager, or other

17 interested party is bound by the independent review organization's

18 determination of the appeal under this section.

19  /s/L. Johnson

20

21

22

23

24

25

26

27

28

29

30

31

32

33

34

35

36

    14                                              03-13-2025 09:57:51 ANS112
Every fact on this page links to its source, starting with the official bill record.